Trial Profile
Clinical Trials Insight: 700032556
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2009
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 05 Dec 2008 Results published in Epilepsia.
- 15 Apr 2008 New trial record.